New asthma treatment shows promise in clinical trial

September 29, 2025 በAI የተዘገበ

Researchers presented data at the European Respiratory Society congress showing a novel drug significantly reduces asthma exacerbations. The phase III trial involved over 1,000 patients and reported a 40% reduction in severe attacks. Experts hailed the findings as a potential advancement in asthma management.

Baxdrostat Effective for Hypertension

A new study revealed that Baxdrostat significantly reduces blood pressure in patients with resistant hypertension. The findings challenge existing treatments and suggest a new option for managing this condition. Results were highlighted as part of recent medical advancements.

FDA issues final rule on clinical trials diversity

The U.S. Food and Drug Administration has finalized a rule requiring drug sponsors to submit diversity action plans for clinical trials. This aims to ensure better representation of underrepresented groups in medical research. The rule takes effect in 2025.

India Approves Autoimmune Drug Trial

September 15, 2025 በAI የተዘገበ

India's CDSCO has approved a new trial for an autoimmune drug by Mankind Pharma, following successful multicentric trials for other medical devices. This development addresses rising needs for treatments amid increasing lifestyle disease deaths. The trial focuses on broad therapeutic applications for autoimmune conditions.